pkanalix software 2023r1 (SAS institute)
SAS institute is a verified supplier 
90
Structured Review
SAS institute
pkanalix software 2023r1
Pkanalix Software 2023r1, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pkanalix/simulx+2024r1/pm40491319-84-9-13
Average 90 stars, based on 1 article reviews
Pkanalix Software 2023r1, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pkanalix/simulx+2024r1/pm40491319-84-9-13
Average 90 stars, based on 1 article reviews
pkanalix software 2023r1 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Clinical Proteomics:Article Title: Metamizole is a Moderate Cytochrome P450 Inducer Via the Constitutive Androstane Receptor and a Weak Inhibitor of CYP1A2. Article Snippet: .. AUCinf, maximal plasma concentration (Cmax), terminal half-life (t1/2), and ke of the cocktail drugs before and after treatment with metamizole were estimated with the noncompartmental methods using Article Title: A physiologically-based pharmacokinetic modeling approach for dosing amiodarone in children on ECMO. Article Snippet: We used R Statistical Software (v4.2.2; R Core Team 2022) for the calculation of amiodarone rate constants using the ex vivo data and GraphPad Prism® (Version 9, GraphPad LLC, CA, USA) for data visualization. .. Amiodarone PK parameters area under the curve (AUC0- 24) and maximum plasma concentration (Cmax) in pediatric patients with or without ECMO, were calculated using noncompartmental method using Article Title: Effect of deglucuronidation on the results of the Basel phenotyping cocktail. Article Snippet: Correspondence Stephan Krähenbühl, MD, PhD Clinical Pharmacology & Toxicology, University Hospital Basel,4031 Basel.. Switzerland.. Email: stephan.kraehenbuehl@usb.ch We investigated the effect of deglucuronidation on the plasma concentration of the constituents of the Basel phenotyping cocktail and on the interpretation of the phenotyping results under basal conditions and after cytochrome P450 (CYP) induction with metamizole. Article Title: Metamizole is a Moderate Cytochrome P450 Inducer Via the Constitutive Androstane Receptor and a Weak Inhibitor of CYP1A2 Article Snippet: .. AUC inf, maximal plasma concentration (C max ), terminal half‐life ( t 1/2 ), and k e of the cocktail drugs before and after treatment with metamizole were estimated with the noncompartmental methods using Concentration Assay:Article Title: Metamizole is a Moderate Cytochrome P450 Inducer Via the Constitutive Androstane Receptor and a Weak Inhibitor of CYP1A2. Article Snippet: .. AUCinf, maximal plasma concentration (Cmax), terminal half-life (t1/2), and ke of the cocktail drugs before and after treatment with metamizole were estimated with the noncompartmental methods using Article Title: A physiologically-based pharmacokinetic modeling approach for dosing amiodarone in children on ECMO. Article Snippet: We used R Statistical Software (v4.2.2; R Core Team 2022) for the calculation of amiodarone rate constants using the ex vivo data and GraphPad Prism® (Version 9, GraphPad LLC, CA, USA) for data visualization. .. Amiodarone PK parameters area under the curve (AUC0- 24) and maximum plasma concentration (Cmax) in pediatric patients with or without ECMO, were calculated using noncompartmental method using Article Title: Effect of deglucuronidation on the results of the Basel phenotyping cocktail. Article Snippet: Correspondence Stephan Krähenbühl, MD, PhD Clinical Pharmacology & Toxicology, University Hospital Basel,4031 Basel.. Switzerland.. Email: stephan.kraehenbuehl@usb.ch We investigated the effect of deglucuronidation on the plasma concentration of the constituents of the Basel phenotyping cocktail and on the interpretation of the phenotyping results under basal conditions and after cytochrome P450 (CYP) induction with metamizole. Article Title: Metamizole is a Moderate Cytochrome P450 Inducer Via the Constitutive Androstane Receptor and a Weak Inhibitor of CYP1A2 Article Snippet: .. AUC inf, maximal plasma concentration (C max ), terminal half‐life ( t 1/2 ), and k e of the cocktail drugs before and after treatment with metamizole were estimated with the noncompartmental methods using Drug discovery:Article Title: Non-compartmental and population pharmacokinetic analysis of dapsone in healthy NIGERIANS: A pilot study. Article Snippet: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Ibadan, Ibadan, Nigeria Centre for Drug Discovery, Development and Production (CDDDP), Faculty of Pharmacy, University of Ibadan, Ibadan, Nigeria Department of Public Health, College of Basic Medical Sciences, Chrisland University, Abeokuta, Nigeria African Institute for Biomedical Sciences and Technology (AiBST), Harare, Zimbabwe Genetic and Bioethics Unit, Institute for Advanced Medical Research and Training (IAMRAT), College of Medicine, University of Ibadan, Ibadan, Nigeria Sickle Cell Hope Alive Foundation, Ibadan, Nigeria Department of Physiology/Pharmacology, College of Basic Medical Sciences, Chrisland University, Abeokuta, Nigeria Generated:Article Title: Effect of deglucuronidation on the results of the Basel phenotyping cocktail. Article Snippet: Correspondence Stephan Krähenbühl, MD, PhD Clinical Pharmacology & Toxicology, University Hospital Basel,4031 Basel.. Switzerland.. Email: stephan.kraehenbuehl@usb.ch We investigated the effect of deglucuronidation on the plasma concentration of the constituents of the Basel phenotyping cocktail and on the interpretation of the phenotyping results under basal conditions and after cytochrome P450 (CYP) induction with metamizole. |